Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Neuronal loss very limited in Alzheimer's disease, new study shows

Neuronal loss very limited in Alzheimer's disease, new study shows

Neuronal loss is very limited in Alzheimer’s disease, shows new study

Neuronal loss is very limited in Alzheimer’s disease, shows new study

Postcard from Sacramento: Alzheimer’s ‘looks like me, it looks like you’

Postcard from Sacramento: Alzheimer’s ‘looks like me, it looks like you’

Study reveals how devastating mitochondrial diseases strike families without any previous history

Study reveals how devastating mitochondrial diseases strike families without any previous history

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

Study finds overall pattern of commonality between Huntington's and Parkinson's

Study finds overall pattern of commonality between Huntington's and Parkinson's

Worsening of anxiety symptoms may be early indicator of Alzheimer's disease

Worsening of anxiety symptoms may be early indicator of Alzheimer's disease

Novel polygenic hazard score captures age variations of aggressive prostate cancer

Novel polygenic hazard score captures age variations of aggressive prostate cancer

Insilico Medicine develops new deep-learning based hematological human aging clock

Insilico Medicine develops new deep-learning based hematological human aging clock

Pfizer to stop Alzheimer’s and Parkinson’s disease research

Pfizer to stop Alzheimer’s and Parkinson’s disease research

Salk scientists identify molecular target of experimental Alzheimer’s drug

Salk scientists identify molecular target of experimental Alzheimer’s drug

Researchers awarded grant to repurpose FDA-approved drugs for treating Alzheimer's patients

Researchers awarded grant to repurpose FDA-approved drugs for treating Alzheimer's patients

Vanderbilt and Lundbeck collaborate to develop novel approach for treating schizophrenia

Vanderbilt and Lundbeck collaborate to develop novel approach for treating schizophrenia

Sangamo and Pfizer partner for development of new zinc finger protein gene therapy to treat ALS

Sangamo and Pfizer partner for development of new zinc finger protein gene therapy to treat ALS

Researchers use Quest MRI to identify earliest signs of Alzheimer's disease in mice

Researchers use Quest MRI to identify earliest signs of Alzheimer's disease in mice

New study uncovers why sauna bathing provides health benefits

New study uncovers why sauna bathing provides health benefits

Powerful imaging technique sheds light on how the brain responds to vascular injury

Powerful imaging technique sheds light on how the brain responds to vascular injury

Testing blood for caffeine levels may aid diagnosis of Parkinson's disease

Testing blood for caffeine levels may aid diagnosis of Parkinson's disease

Researchers discover novel genes responsible for Alzheimer's disease

Researchers discover novel genes responsible for Alzheimer's disease

Advanced live cell imaging reveals brain’s response to blood vessel injury

Advanced live cell imaging reveals brain’s response to blood vessel injury